Medical device development
Its Lipocube subsidiary develops medical devices for extracting and processing autologous adipose-based stem cells.
Source: LinkedIn company description · Retrieved October 13, 2026
Mage Biotechnologies is a holding company active in longevity and regenerative medicine.
Its core areas of expertise are stem-cell-based and exosome-based technologies. The company conducts its business activities through several subsidiaries.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Its Lipocube subsidiary develops medical devices for extracting and processing autologous adipose-based stem cells.
Source: LinkedIn company description · Retrieved October 13, 2026
Its Recure subsidiary develops, produces and markets cosmetics, supplements and injectables featuring its Hybrid Exosomes technology.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 18, 2026, September 19, 2026, September 21, 2026 and September 29, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.